| 注册
首页|期刊导航|解放军医学院学报|经鼻内镜视神经减压治疗外伤性视神经病变的研究进展及展望

经鼻内镜视神经减压治疗外伤性视神经病变的研究进展及展望

王哲 李昉晔

解放军医学院学报2025,Vol.46Issue(9):825-831,847,8.
解放军医学院学报2025,Vol.46Issue(9):825-831,847,8.DOI:10.12435/j.issn.2095-5227.24071602

经鼻内镜视神经减压治疗外伤性视神经病变的研究进展及展望

Research advances and prospect of endoscopic transnasal optic nerve decompression for traumatic optic neuropathy

王哲 1李昉晔2

作者信息

  • 1. 解放军总医院第一医学中心神经外科医学部,北京 100853||解放军医学院,北京 100853||解放军总医院海南医院神经外科,海南 三亚 572013
  • 2. 解放军总医院第一医学中心神经外科医学部,北京 100853
  • 折叠

摘要

Abstract

Traumatic optic neuropathy(TON)is an injury to the optic nerve caused by craniomaxillofacial trauma,characterized by a sudden decline in vision or complete blindness.Clinical interventions for TON include simple observation,corticosteroid therapy,and optic nerve decompression.However,there is controversy over which treatment method is optimal.With advancements in endoscopic techniques,endoscopic transnasal optic nerve decompression(ETOND)has increasingly become a mainstream method for treating TON.Despite this,there is a lack of high-quality randomized controlled trials to evaluate its efficacy.Furthermore,treatment outcomes are influenced by several factors,including the timing of surgery,the severity of vision loss,optic canal fractures,optic nerve sheath incision,and hemorrhage within the ethmoid and/or sphenoid sinuses.This review provides an overview of the recent clinical efficacy,prognostic factors,and technological innovations in ETOND for the treatment of TON.

关键词

外伤性视神经病变/视神经减压术/神经内镜/治疗/预后因素

Key words

traumatic optic neuropathy/optic nerve decompression/neuroendoscopes/therapy/prognostic factors

分类

医药卫生

引用本文复制引用

王哲,李昉晔..经鼻内镜视神经减压治疗外伤性视神经病变的研究进展及展望[J].解放军医学院学报,2025,46(9):825-831,847,8.

基金项目

海南省自然科学基金青年基金项目(819QN378) (819QN378)

省部级课题 ()

解放军医学院学报

2095-5227

访问量0
|
下载量0
段落导航相关论文